Jeffrey E. Russel

Array ( [id] => 860180 [patent_doc_number] => 07371579 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-05-13 [patent_title] => 'Nickel-based reagents for detecting DNA and DNA-protein contacts' [patent_app_type] => utility [patent_app_number] => 10/019655 [patent_app_country] => US [patent_app_date] => 2000-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 13004 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371579.pdf [firstpage_image] =>[orig_patent_app_number] => 10019655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1433452 [patent_doc_number] => 06340742 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-22 [patent_title] => 'Erythropoietin conjugates' [patent_app_type] => B1 [patent_app_number] => 09/604871 [patent_app_country] => US [patent_app_date] => 2000-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7742 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/340/06340742.pdf [firstpage_image] =>[orig_patent_app_number] => 09604871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1046839 [patent_doc_number] => 06864234 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-08 [patent_title] => 'Somatostatin agonists' [patent_app_type] => utility [patent_app_number] => 09/980943 [patent_app_country] => US [patent_app_date] => 2000-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6433 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/864/06864234.pdf [firstpage_image] =>[orig_patent_app_number] => 09980943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1383692 [patent_doc_number] => 06551998 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Antimicrobial agents' [patent_app_type] => B1 [patent_app_number] => 09/599787 [patent_app_country] => US [patent_app_date] => 2000-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10471 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/551/06551998.pdf [firstpage_image] =>[orig_patent_app_number] => 09599787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1564010 [patent_doc_number] => 06375928 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Neutrophil stimulating peptides' [patent_app_type] => B1 [patent_app_number] => 09/598784 [patent_app_country] => US [patent_app_date] => 2000-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9821 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/375/06375928.pdf [firstpage_image] =>[orig_patent_app_number] => 09598784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 544682 [patent_doc_number] => 07169889 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-01-30 [patent_title] => 'Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin' [patent_app_type] => utility [patent_app_number] => 10/018879 [patent_app_country] => US [patent_app_date] => 2000-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14273 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/169/07169889.pdf [firstpage_image] =>[orig_patent_app_number] => 10018879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 720523 [patent_doc_number] => 07049398 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-23 [patent_title] => 'Melanocortin metallopeptide constructs, combinatorial libraries and applications' [patent_app_type] => utility [patent_app_number] => 10/049718 [patent_app_country] => US [patent_app_date] => 2000-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 35479 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 348 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049398.pdf [firstpage_image] =>[orig_patent_app_number] => 10049718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1474936 [patent_doc_number] => 06387882 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Vitamin E derivatives' [patent_app_type] => B1 [patent_app_number] => 09/581588 [patent_app_country] => US [patent_app_date] => 2000-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 7778 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387882.pdf [firstpage_image] =>[orig_patent_app_number] => 09581588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1523933 [patent_doc_number] => 06352977 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Substituted -alanines' [patent_app_type] => B1 [patent_app_number] => 09/589825 [patent_app_country] => US [patent_app_date] => 2000-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25810 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/352/06352977.pdf [firstpage_image] =>[orig_patent_app_number] => 09589825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1113390 [patent_doc_number] => 06803466 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-12 [patent_title] => 'HIV/FIV protease inhibitors having a small P3 residue' [patent_app_type] => B1 [patent_app_number] => 09/581044 [patent_app_country] => US [patent_app_date] => 2000-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 20 [patent_no_of_words] => 19651 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/803/06803466.pdf [firstpage_image] =>[orig_patent_app_number] => 09581044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 580441 [patent_doc_number] => 07445764 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-11-04 [patent_title] => 'Carrier-drug conjugate' [patent_app_type] => utility [patent_app_number] => 10/009854 [patent_app_country] => US [patent_app_date] => 2000-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 7034 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/445/07445764.pdf [firstpage_image] =>[orig_patent_app_number] => 10009854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 758045 [patent_doc_number] => 07015199 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-03-21 [patent_title] => 'Treatment of psoriasis through down-regulation of the EGF-receptor with topically-applied EGF' [patent_app_type] => utility [patent_app_number] => 09/584978 [patent_app_country] => US [patent_app_date] => 2000-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 755 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/015/07015199.pdf [firstpage_image] =>[orig_patent_app_number] => 09584978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1585973 [patent_doc_number] => 06358924 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'GLP-1 formulations' [patent_app_type] => B1 [patent_app_number] => 09/585181 [patent_app_country] => US [patent_app_date] => 2000-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4292 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358924.pdf [firstpage_image] =>[orig_patent_app_number] => 09585181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 856821 [patent_doc_number] => 07375080 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-05-20 [patent_title] => 'Immobilized lactoferrin (Im-LF) antimicrobial agents and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/980062 [patent_app_country] => US [patent_app_date] => 2000-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18159 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/375/07375080.pdf [firstpage_image] =>[orig_patent_app_number] => 09980062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1018010 [patent_doc_number] => 06890904 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-10 [patent_title] => 'Anti-tumor agents' [patent_app_type] => utility [patent_app_number] => 09/578363 [patent_app_country] => US [patent_app_date] => 2000-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 18031 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/890/06890904.pdf [firstpage_image] =>[orig_patent_app_number] => 09578363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1601762 [patent_doc_number] => 06476186 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Process for preparing octreotide and derivatives thereof' [patent_app_type] => B1 [patent_app_number] => 09/576769 [patent_app_country] => US [patent_app_date] => 2000-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1861 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 194 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/476/06476186.pdf [firstpage_image] =>[orig_patent_app_number] => 09576769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1347311 [patent_doc_number] => 06583110 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-24 [patent_title] => 'Use of agents which bind G proteins for treating septic shock' [patent_app_type] => B1 [patent_app_number] => 09/486970 [patent_app_country] => US [patent_app_date] => 2000-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6254 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/583/06583110.pdf [firstpage_image] =>[orig_patent_app_number] => 09486970 [rel_patent_id] =>[rel_patent_doc_number] =>)